Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

156
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
156
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.4K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.6K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

99
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
99
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

104
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
104

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Original scoring system of safety reports for ensuring medical security-trajectory for 18 years at a single center.

Journal of rural medicine : JRM·2024
Same author

[Herpes simplex encephalitis complicated with cerebral salt wasting syndrome: a case study].

Rinsho shinkeigaku = Clinical neurology·2024
Same author

Unusual Presentation of Double-seronegative Myasthenia Gravis with Positive Anti-LRP4 Antibody: Diagnostic Utility of a Videofluoroscopic Swallowing Study.

Internal medicine (Tokyo, Japan)·2024
Same author

Delayed Superior Orbital Fissure Syndrome Arising More than One Month after Herpes Zoster Ophthalmicus and Meningitis.

Internal medicine (Tokyo, Japan)·2024
Same author

Pembrolizumab-induced Myopathy with Anti-striated Muscle Antibodies Successfully Treated by Plasma Exchange.

Internal medicine (Tokyo, Japan)·2023
Same author

[Immune-Mediated Necrotizing Myopathy(IMNM)].

Brain and nerve = Shinkei kenkyu no shinpo·2023

Related Experiment Video

Updated: Nov 18, 2025

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

288

[Immune-Mediated Necrotizing Myopathy: IMNM].

Hiroyuki Tomimitsu1

  • 1Department of Neurology, JA Toride Medical Center.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|February 9, 2021
PubMed
Summary

Immune-mediated necrotizing myopathy (IMNM) is an autoimmune muscle disease causing progressive weakness and muscle fiber death. Early diagnosis and intensive immune-modifying therapies are crucial for better outcomes in IMNM patients.

Area of Science:

  • Neurology
  • Immunology
  • Rheumatology

Background:

  • Immune-mediated necrotizing myopathy (IMNM) is a rare autoimmune disorder.
  • It is characterized by progressive muscle weakness and muscle fiber necrosis without significant inflammation.
  • High serum creatine kinase levels are typical due to skeletal muscle involvement.

Purpose of the Study:

  • To summarize the key features of IMNM.
  • To highlight the diagnostic markers and pathological findings.
  • To emphasize the importance of early and intensive treatment.

Main Methods:

  • Review of clinical presentations.
  • Pathological examination of muscle biopsies.
  • Serological testing for autoantibodies (anti-SRP, anti-HMGCR).

More Related Videos

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.8K
Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

9.2K

Related Experiment Videos

Last Updated: Nov 18, 2025

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

288
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.8K
Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

9.2K

Main Results:

  • IMNM presents with subacute, proximal muscle weakness.
  • Muscle biopsies show prominent necrotic fibers with minimal inflammatory cell infiltration.
  • Autoantibodies anti-SRP and anti-HMGCR are associated with IMNM.
  • IMNM often has a worse functional prognosis compared to other myositis forms.

Conclusions:

  • IMNM is a distinct autoimmune myopathy with specific pathological and serological features.
  • Prompt diagnosis is essential for initiating timely and aggressive immune-modifying therapies.
  • Effective treatment can improve symptoms and potentially alter the disease course.